Trial Profile
Randomized phase II study comparing transcatheter arterial chemo-embolization with Miriplatin and transcatheter arterial chemo-embolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Miriplatin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 27 Aug 2012 New trial record